(For a live blog on the U.S. stock market, click LIVE/ or
type LIVE/ in a news window.)
* Futures down: Dow 0.5%, S&P 0.6%, Nasdaq 0.8%
By Medha Singh
Aug 9 (Reuters) - U.S. stocks futures slipped on Friday, a
day after Wall Street roared back to record its biggest one-day
rise in two months, as investors grappled with fresh trade
tensions and political turmoil in Britain and Italy.
Despite a turbulent week that started with the three main
indexes having their worst one-day percentage fall of 2019 on
renewed trade war fears, the benchmark S&P 500 .SPX has
managed to hold onto small gains as bargain hunters picked up
beaten down stocks.
Worries of the economy slipping into a recession are back,
as the trade war between the United States and China shows
little signs of easing, especially after a symbolic drop in
China's currency earlier this week.
The latest concern was a report that Washington was delaying
a decision about allowing some trade between U.S. companies and
China's telecom equipment maker Huawei again, pressuring
chipmakers and other tariff sensitive stocks. Micron Technology MU.O , Nvidia Corp NVDA.O and Intel
Corp INTC.O fell between 1% and 2% in premarket trading, while
Apple Inc AAPL.O slid 0.9%.
European shares were sharply lower as Italy's ruling League
party Deputy Prime Minister Matteo Salvini declared the
governing coalition to be unworkable, while a report said Prime
Minister Boris Johnson was preparing to hold an election in the
days after "October 31 Brexit deadline".
At 6:57 a.m. ET, Dow e-minis 1YMcv1 were down 137 points,
or 0.52%. S&P 500 e-minis EScv1 were down 17 points, or 0.58%
and Nasdaq 100 e-minis NQcv1 were down 61.25 points, or 0.79%.
Investors looking for safety in turbulent times helped the
defensive sectors, with consumer staples .SPLRCS , utilities
.SPLRCU and real estate .SPLRCR indexes outperforming the
broader S&P 500 this week.
Following a near 12% jump on Thursday, Symantec Corp
SYMC.O gained 2.5% after chipmaker Broadcom Inc AVGO.O
confirmed it would buy the antivirus software maker's enterprise
security unit for $10.7 billion in cash. Nektar Therapeutics NKTR.O shares plunged 34.1% after the
drug developer flagged manufacturing issues with its
experimental cancer drug bempeg.